The University of Wisconsin-Milwaukee Institutional Biosafety Committee (IBC) is a committee comprised of faculty, staff, and community members who oversee biological research at UWM involving recombinant and synthetic nucleic acid molecules in accordance with the National Institutes of Health Guidelines for Research Involving Recombinant and Synthetic Nucleic Acids. In addition to overseeing research involving recombinant DNA or synthetic nucleic acids, the IBC reviews the use of the following:
- Use of any biological agent of a risk group 2 or higher level
- Select agents and toxins
- Dual Use Research of Concern (DURC)
- Stem cell research
- Nanotechnology involving biological agents.
- Human cells/ tissues.
- Teaching activities that involve any of these materials.
It is required that the IBC maintains a membership of a minimum of five individuals, with expertise covering knowledge of recombinant DNA and synthetic nucleic acid molecules, a plant expert, an animal expert, the biological safety officer, the campus veterinarian, the campus physician, and at least two members that are from the community, not affiliated with UWM. A current record of membership is reported annually to the NIH Office of Science Policy (OSP) by the biological safety officer. For more information about the IBC, a meeting schedule, and request for meeting minutes, please contact the Biological Safety Officer.
For more information about IBC Member Requirements, visit the IBC Member Requirements Page.
Julie Oliver, Ph.D.- Mammalian Cell Biologist, Dept. of Biological Sciences
Todd Rex Miller, Ph.D.- Environmental Health and Toxicology, Zilber School of Public Health
Osvaldo Jhonatan Sepulveda-Villet, Ph.D.– Aquacultural Specialist, School of Freshwater Sciences
Ching-Liu Wu, M.S.– Instructional Laboratory Manager, Dept. of Biological Sciences
Bradley De Pons, MLS(ASCP)– Instructional Laboratory Manager, Dept. of Biomedical Sciences
Gyaneshwar Prasad, Ph.D.- Plant/ Microbiological Expert, Dept. of Biological Sciences.
Appointed Community Members:
Bret D. Berglund, CHMM
Amber Enderle, M.S.
Ex-Officio Voting Member and IBC Coordinator
Danielle Rintala, M.S. Biological Safety Officer , Dept. of University Safety and Assurances
Ex-Officio Non-Voting Members
Julia Bonner, M.D.- Campus Health Officer
Beryl R. Forman, D.V.M.- Campus Veterinarian, Dept. of University Safety and Assurances
Melissa Spadanuda, M.B.A– Associate Director of Compliance, Dept. of University Safety and Assurances
Jenelle Reick, Research Safety Program Manager, Dept. of University Safety and Assurances
Fall 2017 Schedule:
DEADLINE FOR SUBMISSIONS: OCTOBER 13, 2017
DEADLINE FOR SUBMISSIONS: NOVEMBER 3, 2017
Note: There will be no meeting in December. Meetings will re-convene in January.
Authority of the IBC
The IBC makes decisions to approve or reject biological research protocols based on the following policies, procedures, guidelines, regulations, and laws:
- The NIH Guidelines for Research Involving Recombinant DNA or Synthetic Nucleic Acid Molecules, amended April 2016, is the most current set of guidelines that the IBC, researchers, and the University as a whole are required to follow. These guidelines outline research involving recombinant DNA, synthetic nucleic acid molecules, human cells, tissues, and blood; human gene transfer; biological agents, biological toxins, viruses, and large-scale culture propagation.
- CDC/ NIH Biosafety in Microbiological and Biomedical Research Laboratories (BMBL), 5th Edition, outlines current standard microbiological practices, laboratory design, laboratory biosafety and biosecurity, risk groups, and biocontainment levels.
- University of Wisconsin-Milwaukee Biosafety Manual, Version 2 (July 2017). This outlines university guidelines and procedures for biological research.
- University of Wisconsin-Milwaukee Chemical Hygiene Plan, which outlines institutional policies regarding the safe use of chemicals in the laboratory.
- OSHA Bloodborne Pathogens Standard 29 CFR 1910.1030, which regulates exposure to any cells, cell lines, tissues, body fluids, and blood originating from humans or non-human primates.
IBC Registration Policies – learn about how protocols are evaluated and approved by the IBC.
IBC FAQs– These FAQs may help you in determining your IBC requirements for your research protocol submissions.
Flow Chart for Protocols Requiring IBC Approval– This shows the evaluation and voting process for review of protocols requiring IBC approval.
IBC Registration Flowchart– Does Note Require Quorum Majority Vote- This shows the evaluation process for a registration not requiring IBC majority vote.
Overview for submitting and gaining approval of an IBC protocol– This is a chart of the approval process.
IBC Protocol Registration Forms and Form Submission– This page has the various registration forms, as well as a place to submit the registration materials.